Drug profile · INN
pegvaliase
PALYNZIQ
pegvaliase (PALYNZIQ) is a phenylalanine hydrolytic enzyme. Associated with BioMarin Pharmaceutical Australia Pty Ltd.
EMA: approved Alimentary tract and metabolism (A16) A16AB19
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — pegvaliase
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 7
- Data quality
- 0.89
Quick answer
pegvaliase (PALYNZIQ) is a phenylalanine hydrolytic enzyme. Associated with BioMarin Pharmaceutical Australia Pty Ltd.
Key facts
INN pegvaliase
Brand PALYNZIQ
Mechanism Phenylalanine hydrolytic enzyme
Target Phenylalanine
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AB19
Originator BioMarin Pharmaceutical Australia Pty Ltd
Mechanism of action
Phenylalanine hydrolytic enzyme
Primary target: Phenylalanine
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pegvaliase?
pegvaliase (PALYNZIQ) is a phenylalanine hydrolytic enzyme. Associated with BioMarin Pharmaceutical Australia Pty Ltd.
What is the brand name for pegvaliase?
PALYNZIQ is a marketed brand name for pegvaliase. Check FDA Drugs@FDA for the current US label holder and prescribing information.